LEGN
Price
$22.32
Change
-$0.96 (-4.12%)
Updated
Jan 15, 11:46 AM (EDT)
Capitalization
4.3B
62 days until earnings call
Intraday BUY SELL Signals
PHAT
Price
$15.05
Change
-$0.09 (-0.59%)
Updated
Jan 15, 12:00 PM (EDT)
Capitalization
1.18B
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LEGN vs PHAT

Header iconLEGN vs PHAT Comparison
Open Charts LEGN vs PHATBanner chart's image
Legend Biotech
Price$22.32
Change-$0.96 (-4.12%)
Volume$3.2K
Capitalization4.3B
Phathom Pharmaceuticals
Price$15.05
Change-$0.09 (-0.59%)
Volume$802
Capitalization1.18B
LEGN vs PHAT Comparison Chart in %
View a ticker or compare two or three
VS
LEGN vs. PHAT commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LEGN is a Hold and PHAT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (LEGN: $23.28 vs. PHAT: $15.14)
Brand notoriety: LEGN and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LEGN: 75% vs. PHAT: 95%
Market capitalization -- LEGN: $4.3B vs. PHAT: $1.18B
LEGN [@Biotechnology] is valued at $4.3B. PHAT’s [@Biotechnology] market capitalization is $1.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LEGN’s FA Score shows that 1 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • LEGN’s FA Score: 1 green, 4 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, LEGN is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LEGN’s TA Score shows that 5 TA indicator(s) are bullish while PHAT’s TA Score has 3 bullish TA indicator(s).

  • LEGN’s TA Score: 5 bullish, 3 bearish.
  • PHAT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, LEGN is a better buy in the short-term than PHAT.

Price Growth

LEGN (@Biotechnology) experienced а +2.46% price change this week, while PHAT (@Biotechnology) price change was -16.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

LEGN is expected to report earnings on Mar 18, 2026.

PHAT is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LEGN($4.3B) has a higher market cap than PHAT($1.18B). LEGN YTD gains are higher at: 7.084 vs. PHAT (-8.740). LEGN has higher annual earnings (EBITDA): -176.13M vs. PHAT (-203.56M). LEGN has more cash in the bank: 993M vs. PHAT (135M). PHAT has less debt than LEGN: PHAT (210M) vs LEGN (410M). LEGN has higher revenues than PHAT: LEGN (909M) vs PHAT (147M).
LEGNPHATLEGN / PHAT
Capitalization4.3B1.18B364%
EBITDA-176.13M-203.56M87%
Gain YTD7.084-8.740-81%
P/E RatioN/AN/A-
Revenue909M147M618%
Total Cash993M135M736%
Total Debt410M210M195%
FUNDAMENTALS RATINGS
PHAT: Fundamental Ratings
PHAT
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LEGNPHAT
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 11 days ago
80%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LEGN
Daily Signal:
Gain/Loss:
PHAT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAVKX15.010.17
+1.15%
MoA Small Cap Value Fund
NRIQX14.820.07
+0.47%
Neuberger International Eq R6
RYVFX10.130.02
+0.20%
Royce Small-Cap Value Service
JCPRX24.15-0.20
-0.82%
JPMorgan US Large Cap Core Plus R5
MFEKX198.61-2.51
-1.25%
MFS Growth R6

LEGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LEGN has been loosely correlated with CLDX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LEGN jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEGN
1D Price
Change %
LEGN100%
+3.15%
CLDX - LEGN
44%
Loosely correlated
+1.58%
BEAM - LEGN
42%
Loosely correlated
+2.49%
KURA - LEGN
42%
Loosely correlated
+1.63%
IDYA - LEGN
41%
Loosely correlated
+5.53%
RGNX - LEGN
40%
Loosely correlated
-0.66%
More

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with RGNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
-3.13%
RGNX - PHAT
40%
Loosely correlated
-0.66%
QCLS - PHAT
39%
Loosely correlated
+5.76%
ATRA - PHAT
36%
Loosely correlated
+2.29%
URGN - PHAT
36%
Loosely correlated
-5.50%
LEGN - PHAT
36%
Loosely correlated
+3.15%
More